Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology

This is a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology on the role of echocardiography in monitoring patients receiving dopamine agonist (DA) therapy for hyperprolactinaemia. (1) Evidence that DA pharmacotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Steeds, Richard P, Stiles, Craig E, Sharma, Vishal, Chambers, John B, Lloyd, Guy, Drake, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Guidelines and Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391931/
https://www.ncbi.nlm.nih.gov/pubmed/30825409
http://dx.doi.org/10.1530/ERP-18-0069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391931/
https://www.ncbi.nlm.nih.gov/pubmed/30825409
http://dx.doi.org/10.1530/ERP-18-0069

Ejemplares similares